Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Clinical trial NCT03623633 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03623633
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2023-02-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.